| Product Code: ETC9974172 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a notable increase in posaconazole import shipments in 2024, with top exporting countries being Switzerland, Ireland, Singapore, India, and Germany. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), decreased from moderate to low in 2024, indicating a more diverse import market. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.85%, with a significant growth rate of 7.62% from 2023 to 2024, reflecting a positive trend in the importation of posaconazole into the United States.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Posaconazole Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Posaconazole Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Posaconazole Market - Industry Life Cycle |
3.4 United States (US) Posaconazole Market - Porter's Five Forces |
3.5 United States (US) Posaconazole Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 United States (US) Posaconazole Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 United States (US) Posaconazole Market Revenues & Volume Share, By End-Users, 2022 & 2032F |
3.8 United States (US) Posaconazole Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 United States (US) Posaconazole Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of invasive fungal infections in the United States |
4.2.2 Rising awareness about the benefits of posaconazole in treating fungal infections |
4.2.3 Growing adoption of posaconazole as a first-line treatment option for certain fungal diseases |
4.3 Market Restraints |
4.3.1 High cost associated with posaconazole treatment |
4.3.2 Limited access to posaconazole in certain healthcare settings due to formulary restrictions |
4.3.3 Competition from alternative antifungal treatments |
5 United States (US) Posaconazole Market Trends |
6 United States (US) Posaconazole Market, By Types |
6.1 United States (US) Posaconazole Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Posaconazole Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 United States (US) Posaconazole Market Revenues & Volume, By Injection, 2022 - 2032F |
6.1.4 United States (US) Posaconazole Market Revenues & Volume, By Delayed-release Tablets, 2022 - 2032F |
6.1.5 United States (US) Posaconazole Market Revenues & Volume, By Oral Suspension, 2022 - 2032F |
6.1.6 United States (US) Posaconazole Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 United States (US) Posaconazole Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Posaconazole Market Revenues & Volume, By Prophylaxis of Invasive Aspergillus, 2022 - 2032F |
6.2.3 United States (US) Posaconazole Market Revenues & Volume, By Candida Infections, 2022 - 2032F |
6.2.4 United States (US) Posaconazole Market Revenues & Volume, By Oropharyngeal Candidiasis(OPC), 2022 - 2032F |
6.2.5 United States (US) Posaconazole Market Revenues & Volume, By Invasive Infections by Candida, 2022 - 2032F |
6.2.6 United States (US) Posaconazole Market Revenues & Volume, By Mucor and Aspergillus Species, 2022 - 2032F |
6.2.7 United States (US) Posaconazole Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 United States (US) Posaconazole Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Posaconazole Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.3.3 United States (US) Posaconazole Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.4 United States (US) Posaconazole Market Revenues & Volume, By Diagnostic centres, 2022 - 2032F |
6.3.5 United States (US) Posaconazole Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 United States (US) Posaconazole Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Posaconazole Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.4.3 United States (US) Posaconazole Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
6.4.4 United States (US) Posaconazole Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
7 United States (US) Posaconazole Market Import-Export Trade Statistics |
7.1 United States (US) Posaconazole Market Export to Major Countries |
7.2 United States (US) Posaconazole Market Imports from Major Countries |
8 United States (US) Posaconazole Market Key Performance Indicators |
8.1 Number of new prescriptions for posaconazole |
8.2 Percentage of healthcare providers recommending posaconazole as a treatment option |
8.3 Patient adherence rate to posaconazole treatment |
8.4 Number of clinical trials evaluating the efficacy of posaconazole for new indications |
9 United States (US) Posaconazole Market - Opportunity Assessment |
9.1 United States (US) Posaconazole Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 United States (US) Posaconazole Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 United States (US) Posaconazole Market Opportunity Assessment, By End-Users, 2022 & 2032F |
9.4 United States (US) Posaconazole Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 United States (US) Posaconazole Market - Competitive Landscape |
10.1 United States (US) Posaconazole Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Posaconazole Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here